Somers G, LHermine-Coulomb A, Matoso A, OSullivan M
Virchows Arch. 2025; 486(1):49-64.
PMID: 39786574
DOI: 10.1007/s00428-024-04017-x.
Nasrallah O, AlJardali B, El Asmar J, El Kasti A, Hajj A
Ann Med Surg (Lond). 2024; 86(10):6198-6202.
PMID: 39359825
PMC: 11444545.
DOI: 10.1097/MS9.0000000000002479.
Xu M, Fu J, Cai L
BMC Womens Health. 2024; 24(1):527.
PMID: 39304877
PMC: 11414286.
DOI: 10.1186/s12905-024-03364-w.
Lobo J, Ohashi R, Helmchen B, Rupp N, Ruschoff J, Moch H
Biomedicines. 2021; 9(10).
PMID: 34680535
PMC: 8533532.
DOI: 10.3390/biomedicines9101418.
Cimadamore A, Cheng L, Scarpelli M, Massari F, Mollica V, Santoni M
Transl Androl Urol. 2021; 10(3):1506-1520.
PMID: 33850785
PMC: 8039604.
DOI: 10.21037/tau-20-1150.
MiT family translocation renal cell carcinomas: A 15th anniversary update.
Gandhi J, Malik F, Amin M, Argani P, Bahrami A
Histol Histopathol. 2019; 35(2):125-136.
PMID: 31489603
DOI: 10.14670/HH-18-159.
"High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.
He H, Trpkov K, Martinek P, Isikci O, Maggi-Galuzzi C, Alaghehbandan R
Virchows Arch. 2018; 473(6):725-738.
PMID: 30232607
DOI: 10.1007/s00428-018-2456-4.
Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion.
Ling W, Ma X, Luo Y, Chen L, Wang H, Wang X
Contrast Media Mol Imaging. 2018; 2017:2958357.
PMID: 29333109
PMC: 5733203.
DOI: 10.1155/2017/2958357.
[WHO classification 2016 and first S3 guidelines on renal cell cancer: What is important for the practice?].
Moch H
Pathologe. 2016; 37(2):127-33.
PMID: 26942728
DOI: 10.1007/s00292-016-0144-1.
Cardiopulmonary bypass-assisted surgery for the treatment of Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a tumor thrombus within the inferior vena cava: A case report.
Zhu G, Qiu X, Chen X, Liu G, Zhang G, Gan W
Oncol Lett. 2016; 10(6):3532-3534.
PMID: 26788164
PMC: 4665330.
DOI: 10.3892/ol.2015.3739.
Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
Pradhan D, Roy S, Quiroga-Garza G, Cieply K, Mahaffey A, Bastacky S
Diagn Pathol. 2015; 10:179.
PMID: 26415891
PMC: 4587681.
DOI: 10.1186/s13000-015-0412-z.
TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
Xu Y, Rao Q, Xia Q, Shi S, Shi Q, Ma H
Int J Clin Exp Pathol. 2015; 8(3):2690-9.
PMID: 26045774
PMC: 4440083.
Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.
Geller J, Ehrlich P, Cost N, Khanna G, Mullen E, Gratias E
Cancer. 2015; 121(14):2457-64.
PMID: 25845370
PMC: 4588054.
DOI: 10.1002/cncr.29368.
Xp 11.2 translocation renal carcinoma in young adults; recently classified distinct subtype.
Kmetec A, Jeruc J
Radiol Oncol. 2014; 48(2):197-202.
PMID: 24991210
PMC: 4078039.
DOI: 10.2478/raon-2013-0077.
Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Wang W, Ding J, Li Y, Wang C, Zhou L, Zhu H
PLoS One. 2014; 9(6):e99990.
PMID: 24926688
PMC: 4057389.
DOI: 10.1371/journal.pone.0099990.
Renal cell carcinoma with t(X;17)(p11.2;q25) in a 5-year-old Taiwanese boy: a case report and review of the literature.
Chen C, Hsu H, Lin M, Pintye M, Chen J
Pathol Oncol Res. 2011; 18(1):111-6.
PMID: 21221873
DOI: 10.1007/s12253-010-9353-8.
Targeting the Met signaling pathway in renal cancer.
Giubellino A, Linehan W, Bottaro D
Expert Rev Anticancer Ther. 2009; 9(6):785-93.
PMID: 19496715
PMC: 2737331.
DOI: 10.1586/era.09.43.
Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature.
Armah H, Parwani A, Surti U, Bastacky S
Diagn Pathol. 2009; 4:15.
PMID: 19450277
PMC: 2690580.
DOI: 10.1186/1746-1596-4-15.
